Again, we would be very pleased to hear from the firms that you're talking about. We are working through those firms that have put forward orders for remission. It's important that we ensure the market remains stable, and we think the safeguards will have an important impact on that. It's also important that we consider the remission requests with an eye towards ensuring they're valid.
We put in place the tariffs on the United States on a dollar-for-dollar basis because we wanted to demonstrate very clearly that the tariffs they put in place were inappropriate. I share your outrage. This is not a situation that we want to be in. But if we go ahead with putting in remission orders without doing our homework, we'll be reducing the impact of those tariffs. We will do that if it's appropriate and if people are really being impacted. That is absolutely our goal. We do not want Canadian firms to be impacted. By the same token, we also want to have the ability to negotiate a conclusion with the United States, and we believe those reciprocal tariffs are instrumental in our ability to do that.
We acknowledge we have to do many things at the same time here. To the extent that these programs can be improved, we are keen to hear your advice, but we're not going to back down from the tariffs and we're going to keep working with companies to deal with the impacts.